Serum Pentraxin 3 as a Biomarker of Hepatocellular Carcinoma in Egyptian Liver Cirrhotic Patients

Abstract

Article informationBackground: Hepatocellular carcinoma [HCC] is the most common primary hepatic cancer in adults, accounting for 70.48% of all liver malignancies in Egypt. The aim of the work:To assess the potential diagnostic value of serum PTX3 level in Egyptian patients with various stages of liver disease including chronic hepatitis, cirrhosis, and HCC, to assess its potential in distinguishing HCC from cirrhosis.